» Authors » Xiao-Hui Niu

Xiao-Hui Niu

Explore the profile of Xiao-Hui Niu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 266
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu Z, Li Y, Yang X, Li Y, He Y, Niu X, et al.
World J Gastrointest Oncol . 2024 Oct; 16(10):4104-4114. PMID: 39473950
Background: The colon cancer prognosis is influenced by multiple factors, including clinical, pathological, and non-biological factors. However, only a few studies have focused on computed tomography (CT) imaging features. Therefore,...
2.
Xia H, Lan J, Jiang L, Yang H, Niu X
Zhongguo Gu Shang . 2023 Apr; 36(4):376-80. PMID: 37087629
Objective: To explore clinical effect of open reduction and internal fixation with Henry's approach butterfly plate in treating double-column Die-punch fractures of distal radius. Methods: From January 2018 to June...
3.
Niu X, Liu R, Lv X, He R, Lv F, Wu S, et al.
Inflamm Res . 2023 Mar; 72(4):879-892. PMID: 36912917
Background: Monocytes/macrophages play critical roles in inflammation and cardiac remodeling following myocardial infarction (MI). The cholinergic anti-inflammatory pathway (CAP) modulates local and systemic inflammatory responses by activating α7 nicotinic acetylcholine...
4.
Gong L, Liu W, Niu X, Ding Y
Diagn Pathol . 2022 Oct; 17(1):80. PMID: 36229858
Background: Recently, a novel group of CD34 and S100 co-expression spindle cell tumors with distinctive stromal and perivascular hyalinization harboring recurrent gene fusions involving RET, RAF1, BRAF, and NTRK1/2 gene...
5.
Wen X, Pan Q, Xu B, Xiao W, Weng D, Zhao J, et al.
Cancer Chemother Pharmacol . 2022 Jan; 89(2):209-215. PMID: 35022817
Purpose: The repeated use of doxorubicin is limited due to dose-limiting cardiac toxicity. Pegylated liposomal doxorubicin (PEG-LD, Duomeisu) has a reduced cardiac toxicity. This phase I study aimed to investigate...
6.
Xu L, Zhang Q, Zhao H, Yu F, Niu X
Chin Med J (Engl) . 2021 Nov; 134(21):2597-2602. PMID: 34748525
Background: Computed tomography (CT) and magnetic resonance imaging (MRI) data can be fused to identify the tumor boundaries. This enables surgeons to set close but tumor-free surgical margins and excise...
7.
Deng Z, Zhao H, Sun Y, Jin T, Ding Y, Niu X
Zhongguo Gu Shang . 2021 Jun; 34(6):527-30. PMID: 34180171
Objective: To analyze the results of percutaneous core needle biopsy for bone tumors in upper limbs with pathologic fracture and to find the possible factors that could impact the results....
8.
Que Y, Zhang X, Liu Z, Zhao J, Pan Q, Wen X, et al.
J Immunother Cancer . 2021 Feb; 9(2). PMID: 33637599
Background: The advent of immune checkpoint therapy has been a tremendous advance in cancer treatment. However, the responses are still insufficient in patients with soft tissue sarcoma (STS). We aimed...
9.
Guo X, Yang W, Yang Q, Yuan Z, Liu Y, Niu X, et al.
Curr Med Sci . 2021 Jan; 40(6):1156-1160. PMID: 33428144
The mutation status of KRAS is a significant biomarker in the prognosis of rectal cancer. This study investigated the feasibility of MRI-based radiomics in predicting the mutation status of KRAS...
10.
Liu Y, Lv H, Tan R, An X, Niu X, Liu Y, et al.
Hypertension . 2020 Nov; 76(6):1856-1867. PMID: 33175633
Hypertension is a risk factor of atrial fibrillation (AF), and a certain number of patients with hypertension were found with an enlarged left atrium. Platelet activation is found in patients...